NCT01447225 - Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2014

Conditions

Solid Tumors

Interventions

DRUG

MM-121

MM-121 administered at 20 mg/kg IV loading dose followed by12mg/kg/week IV or 40 mg/kg IV loading dose followed by 20mg/kg/week IV

DRUG

Carboplatin

administered at AUC 6

DRUG

Pemetrexed

administered IV at 500 mg/m2

DRUG

Cabazitaxel

administered IV at 20 mg/m2 or 25 mg/m2

DRUG

Gemcitabine

administered IV at 1000 mg/m2 or 1250 mg/m2

Trial Locations (5)

Buffalo

Philadelphia

Cincinnati

Lafayette

Villejuif